Literature DB >> 20133944

c-Cbl promotes T cell receptor-induced thymocyte apoptosis by activating the phosphatidylinositol 3-kinase/Akt pathway.

Christine B F Thien1, Samantha A Dagger, James H Steer, Frank Koentgen, Elisa S Jansen, Clare L Scott, Wallace Y Langdon.   

Abstract

The ability of thymocytes to assess T cell receptor (TCR) signaling strength and initiate the appropriate downstream response is crucial for determining their fate. We have previously shown that a c-Cbl RING finger mutant knock-in mouse, in which the E3 ubiquitin ligase activity of c-Cbl is inactivated, is highly sensitive to TCR-induced death signals that cause thymic deletion. This high intensity signal involves the enhanced tyrosine phosphorylation of the mutant c-Cbl protein promoting a marked increase in the activation of Akt. Here we show that this high intensity signal in c-Cbl RING finger mutant thymocytes also promotes the enhanced induction of two mediators of TCR-directed thymocyte apoptosis, Nur77 and the pro-apoptotic Bcl-2 family member, Bim. In contrast, a knock-in mouse harboring a mutation at Tyr-737, the site in c-Cbl that activates phosphatidylinositol 3-kinase, shows reduced TCR-mediated responses including suppression of Akt activation, a reduced induction of Nur77 and Bim, and greater resistance to thymocyte death. These findings identify tyrosine-phosphorylated c-Cbl as a critical sensor of TCR signal strength that regulates the engagement of death-promoting signals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133944      PMCID: PMC2856302          DOI: 10.1074/jbc.M109.094920

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.

Authors:  C A Joazeiro; S S Wing; H Huang; J D Leverson; T Hunter; Y C Liu
Journal:  Science       Date:  1999-10-08       Impact factor: 47.728

2.  Perturbed regulation of ZAP-70 and sustained tyrosine phosphorylation of LAT and SLP-76 in c-Cbl-deficient thymocytes.

Authors:  C B Thien; D D Bowtell; W Y Langdon
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

3.  Altered thymic positive selection and intracellular signals in Cbl-deficient mice.

Authors:  M Naramura; H K Kole; R J Hu; H Gu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 4.  Mechanisms and consequences of activation of protein kinase B/Akt.

Authors:  J Downward
Journal:  Curr Opin Cell Biol       Date:  1998-04       Impact factor: 8.382

5.  Atypical isoforms of pKc and insulin secretion from pancreatic beta-cells: evidence using Gö 6976 and Ro 31-8220 as Pkc inhibitors.

Authors:  T E Harris; S J Persaud; P M Jones
Journal:  Biochem Biophys Res Commun       Date:  1996-10-23       Impact factor: 3.575

6.  Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases.

Authors:  M Deckert; C Elly; A Altman; Y C Liu
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

7.  Fyn, Yes, and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells.

Authors:  E A Feshchenko; W Y Langdon; A Y Tsygankov
Journal:  J Biol Chem       Date:  1998-04-03       Impact factor: 5.157

8.  The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain.

Authors:  C E Andoniou; C B Thien; W Y Langdon
Journal:  Oncogene       Date:  1996-05-02       Impact factor: 9.867

9.  A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection.

Authors:  B J Calnan; S Szychowski; F K Chan; D Cado; A Winoto
Journal:  Immunity       Date:  1995-09       Impact factor: 31.745

10.  Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice.

Authors:  M A Murphy; R G Schnall; D J Venter; L Barnett; I Bertoncello; C B Thien; W Y Langdon; D D Bowtell
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

View more
  14 in total

Review 1.  Targeting Cdc20 as a novel cancer therapeutic strategy.

Authors:  Lixia Wang; Jinfang Zhang; Lixin Wan; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Pharmacol Ther       Date:  2015-04-04       Impact factor: 12.310

Review 2.  RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis.

Authors:  Stanley Lipkowitz; Allan M Weissman
Journal:  Nat Rev Cancer       Date:  2011-08-24       Impact factor: 60.716

3.  Indispensable roles of mammalian Cbl family proteins as negative regulators of protein tyrosine kinase signaling: Insights from in vivo models.

Authors:  Mayumi Naramura; Vimla Band; Hamid Band
Journal:  Commun Integr Biol       Date:  2011-03

4.  CD5 signalosome coordinates antagonist TCR signals to control the generation of Treg cells induced by foreign antigens.

Authors:  Gaëtan Blaize; Hélène Daniels-Treffandier; Meryem Aloulou; Nelly Rouquié; Cui Yang; Marlène Marcellin; Mylène Gador; Mehdi Benamar; Mariette Ducatez; Ki-Duk Song; Odile Burlet-Schiltz; Abdelhadi Saoudi; Paul E Love; Nicolas Fazilleau; Anne Gonzalez de Peredo; Renaud Lesourne
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-20       Impact factor: 11.205

5.  The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival.

Authors:  Naga Suresh Adapala; Mary F Barbe; Wallace Y Langdon; Mary C Nakamura; Alexander Y Tsygankov; Archana Sanjay
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

6.  Rapidly fatal myeloproliferative disorders in mice with deletion of Casitas B-cell lymphoma (Cbl) and Cbl-b in hematopoietic stem cells.

Authors:  Mayumi Naramura; Neha Nandwani; Hua Gu; Vimla Band; Hamid Band
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

7.  Loss of Cbl-PI3K interaction in mice prevents significant bone loss following ovariectomy.

Authors:  Naga Suresh Adapala; Danielle Holland; Vanessa Scanlon; Mary F Barbe; Wallace Y Langdon; Alexander Y Tsygankov; Joseph A Lorenzo; Archana Sanjay
Journal:  Bone       Date:  2014-07-01       Impact factor: 4.398

8.  APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction.

Authors:  Lixin Wan; Mingjia Tan; Jie Yang; Hiroyuki Inuzuka; Xiangpeng Dai; Tao Wu; Jia Liu; Shavali Shaik; Guoan Chen; Jing Deng; Marcos Malumbres; Anthony Letai; Marc W Kirschner; Yi Sun; Wenyi Wei
Journal:  Dev Cell       Date:  2014-05-27       Impact factor: 12.270

9.  Abrogation of Cbl-PI3K interaction increases bone formation and osteoblast proliferation.

Authors:  Tracy Brennan; Naga Suresh Adapala; Mary F Barbe; Vanessa Yingling; Archana Sanjay
Journal:  Calcif Tissue Int       Date:  2011-09-28       Impact factor: 4.333

10.  Ubiquitin ligase Cbl-b is involved in icotinib (BPI-2009H)-induced apoptosis and G1 phase arrest of EGFR mutation-positive non-small-cell lung cancer.

Authors:  Xiaodong Mu; Ye Zhang; Xiujuan Qu; Kezuo Hou; Jian Kang; Xuejun Hu; Yunpeng Liu
Journal:  Biomed Res Int       Date:  2013-03-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.